Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
Advances in Pharmacology (San Diego, Calif.)|August 11, 2022
Cytochrome P450 enzymes in the pediatric population: Connecting knowledge on P450 expression with pediatric pharmacokineticsChie Emoto, Trevor N Johnson
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2019
Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?Parinda A Mehta, Chie Emoto, Tsuyoshi Fukuda, et al.
Drug Metabolism Letters|April 10, 2009
Effects of enzyme sources on midazolam 1'-hydroxylation activity catalyzed by recombinant cytochrome P450 3A4 in combination with NADPH-cytochrome P450 reductaseChie Emoto, Norie Murayama, Hiroshi Yamazaki
Therapeutic Drug Monitoring|August 28, 2014
Age-dependent changes in sirolimus metabolite formation in patients with neurofibromatosis type 1Chie Emoto, Tsuyoshi Fukuda, Tomoyuki Mizuno, et al.
Drug Metabolism Letters|August 26, 2009
Effects of histidine-tag on recombinant human cytochrome P450 3A5 catalytic activity in reconstitution systemsChie Emoto, Norie Murayama, Sachiko Wakiya, et al.
Biopharmaceutics & Drug Disposition|December 3, 2014
Human pharmacokinetic profiling of the dipeptidyl peptidase-IV inhibitor teneligliptin using physiologically based pharmacokinetic modelingYoshinobu Nakamaru, Chie Emoto, Makiko Shimizu, et al.
Drug Metabolism and Pharmacokinetics|November 8, 2005
In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525AChie Emoto, Shigeo Murase, Yasufusa Sawada, et al.
Current Drug Metabolism|January 29, 2008
Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5Toshiro Niwa, Norie Murayama, Chie Emoto, et al.
European Journal of Medicinal Chemistry|August 18, 2012
Discovery of 1-(β-amino substituted-β-alanyl)-N,N-dimethylindoline-2-carboxamides as novel nonpeptide antagonists of nociceptin/orphanin FQ receptor: efficient design, synthesis, and structure-activity relationship studiesShigeo Hayashi, Katsuyo Ohashi, Eriko Nakata, et al.
Drug Metabolism and Pharmacokinetics|May 16, 2021
Feasibility of physiologically based pharmacokinetic simulations for assessing pediatric patients after accidental drug ingestion: A case study of a 1.4-year-old girl who ingested alprazolamChie Emoto, Makiko Shimizu, Toshihiro Tanaka, et al.
Pageof 14